8-K: Scorpius Holdings Faces Delisting Threat After Failing to File Quarterly Report

Scorpius Holdings has received a notice from the NYSE American LLC for failing to file its quarterly report, putting the company at risk of delisting.

Summary

• Scorpius Holdings was unable to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, by the extended deadline of May 20, 2024.
• The company received a notice from the NYSE Regulation stating it is not in compliance with continued listing standards due to the late filing.
• The delay in filing the quarterly report was partly due to the time required to complete and file the 2023 Annual Report on Form 10-K, which was filed on April 26, 2024, after an initial delay.
• Scorpius Holdings is working to complete the necessary procedures and expects to file the Form 10-Q by May 31, 2024, but there is no guarantee it will meet this deadline.
• The company is now subject to monitoring by the NYSE, and if the filing delinquency is not resolved within a six-month period, the company could face suspension and delisting procedures.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the company's failure to meet filing deadlines and the risk of delisting. While the company is working to rectify the situation, the uncertainty and potential consequences weigh heavily on the outlook.

Positives

• The company is working diligently to complete the necessary work to file the Form 10-Q as soon as practicable.
• The company expects to file the Form 10-Q by May 31, 2024.
• The company does not expect the financial results in the Form 10-Q to differ materially from preliminary information reported earlier.

Negatives

• Scorpius Holdings failed to meet the extended deadline for filing its quarterly report.
• The company received a notice of non-compliance from the NYSE American LLC.
• The company is at risk of suspension and delisting if the filing delinquency is not resolved within the cure period.
• There is no assurance that the company will meet the new expected filing date of May 31, 2024.

Risks

• The company faces the risk of suspension and delisting from the NYSE American LLC if it does not file its delinquent quarterly report within the cure period.
• The NYSE may decide not to grant any cure period or truncate the cure period if it believes continued listing is inadvisable.
• There is no guarantee that the company will regain compliance with all applicable Exchange listing standards.

Future Outlook

The company expects to file the Form 10-Q by May 31, 2024, but there is no assurance that this deadline will be met. The company is subject to monitoring by the NYSE and could face delisting if the filing delinquency is not resolved.

Management Comments

• The company is working diligently to complete the necessary work to file the Form 10-Q as soon as practicable.
• The company does not expect the financial results that will be included in the Form 10-Q to differ materially from the preliminary financial information reported in the May Form 12b-25.

Industry Context

This announcement highlights the challenges faced by companies in meeting regulatory filing deadlines, which can lead to significant consequences such as delisting. It underscores the importance of robust internal controls and timely financial reporting.

Comparison to Industry Standards

• Failure to file quarterly reports on time is a serious breach of listing requirements for companies on the NYSE American LLC.
• Companies like Sorrento Therapeutics and Cassava Sciences have faced similar delisting threats due to late filings, highlighting the importance of timely financial reporting.
• The standard cure period for such delinquencies is typically six months, which Scorpius Holdings is now subject to.

Stakeholder Impact

• Shareholders face the risk of significant losses if the company is delisted.
• Employees may experience uncertainty about the company's future.
• Creditors may be concerned about the company's ability to meet its obligations.

Next Steps

• The company must file its Quarterly Report on Form 10-Q by the end of the cure period to avoid delisting.
• The company will be monitored by the NYSE during the six-month cure period.
• The company needs to complete its quarter-end procedures and file the Form 10-Q as soon as practicable.

Key Dates

Keywords

Delisting, NYSE American LLC, Quarterly Report, Form 10-Q, Filing Delinquency, Compliance, SEC, Scorpius Holdings